Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuko Takeda

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Dementia and Geriatric Cognitive Disorders|August 15, 2012
Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's diseaseShuko Takeda, Naoyuki Sato, Kozue Uchio-Yamada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 7, 2026
Correction: Current updates on latest basic research of scientific relevance in hypertensive dementiaMasaki Mogi, Yoichi Takami, Masafumi Ihara, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 5, 2025
Current updates on latest basic research of scientific relevance in hypertensive dementiaMasaki Mogi, Yoichi Takami, Masafumi Ihara, et al.
International Journal of Molecular Medicine|April 22, 2008
Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse modelHitomi Kurinami, Naoyuki Sato, Mitsuru Shinohara, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 4, 2013
Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's diseaseShuko Takeda, Tadafumi Hashimoto, Allyson D Roe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 18, 2026
EXPRESS: Fibroblast Activation Protein Protects the Ischemic Brain Through Regulation of Post-Ischemic InflammationNan Ju, Chin Yang Chang, Hiroki Hayashi, et al.
Brain Research|May 26, 2009
Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer diseaseShuko Takeda, Naoyuki Sato, Kazue Niisato, et al.
Molecular Neurodegeneration|February 15, 2017
Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid β productionKatarzyna Marta Zoltowska, Masato Maesako, Iryna Lushnikova, et al.
Hypertension (Dallas, Tex. : 1979)|October 7, 2009
Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular couplingShuko Takeda, Naoyuki Sato, Daisuke Takeuchi, et al.
The Journal of Biological Chemistry|May 18, 2010
Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearanceMitsuru Shinohara, Naoyuki Sato, Hitomi Kurinami, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Dementia and Geriatric Cognitive Disorders|August 15, 2012
Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's diseaseShuko Takeda, Naoyuki Sato, Kozue Uchio-Yamada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 7, 2026
Correction: Current updates on latest basic research of scientific relevance in hypertensive dementiaMasaki Mogi, Yoichi Takami, Masafumi Ihara, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 5, 2025
Current updates on latest basic research of scientific relevance in hypertensive dementiaMasaki Mogi, Yoichi Takami, Masafumi Ihara, et al.
International Journal of Molecular Medicine|April 22, 2008
Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse modelHitomi Kurinami, Naoyuki Sato, Mitsuru Shinohara, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 4, 2013
Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's diseaseShuko Takeda, Tadafumi Hashimoto, Allyson D Roe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 18, 2026
EXPRESS: Fibroblast Activation Protein Protects the Ischemic Brain Through Regulation of Post-Ischemic InflammationNan Ju, Chin Yang Chang, Hiroki Hayashi, et al.
Brain Research|May 26, 2009
Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer diseaseShuko Takeda, Naoyuki Sato, Kazue Niisato, et al.
Molecular Neurodegeneration|February 15, 2017
Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid β productionKatarzyna Marta Zoltowska, Masato Maesako, Iryna Lushnikova, et al.
Hypertension (Dallas, Tex. : 1979)|October 7, 2009
Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular couplingShuko Takeda, Naoyuki Sato, Daisuke Takeuchi, et al.
The Journal of Biological Chemistry|May 18, 2010
Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearanceMitsuru Shinohara, Naoyuki Sato, Hitomi Kurinami, et al.
Pageof 7